{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:33:25Z","timestamp":1792787605515,"version":"4.5.0"},"reference-count":96,"publisher":"American Association for Cancer Research (AACR)","issue":"14","license":[{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"vor","delay-in-days":53,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007316","name":"Division of Cancer Prevention, National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA195670"],"award-info":[{"award-number":["R01 CA195670"]}],"id":[{"id":"10.13039\/100007316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020125","name":"Baylor Scott & White Research Institute","doi-asserted-by":"crossref","award":["CP14"],"award-info":[{"award-number":["CP14"]}],"id":[{"id":"10.13039\/100020125","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Markel Accelerator Fund","award":["M01"],"award-info":[{"award-number":["M01"]}]},{"DOI":"10.13039\/100007316","name":"Division of Cancer Prevention, National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA033572"],"award-info":[{"award-number":["P30CA033572"]}],"id":[{"id":"10.13039\/100007316","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT), is a rare, deadly form of ovarian cancer that uniformly harbors mutations in SMARCA4, a member of the SWI\/SNF chromatin remodeling complex. SWI\/SNF impacts RNA splicing, and dysregulation of splicing can generate immunogenic tumor antigens. In this study, we explored the relationship between SMARCA4 loss and RNA splicing dysregulation. SCCOHT primary tumors harbored tumor-associated outlier splicing events compared with normal tissues. Many of the tumor events were retained introns encoding novel peptides predicted to bind to MHC-I complexes. Immune cells were observed in primary SCCOHT tumors, suggesting a potentially immune-reactive tumor microenvironment. Mutations in several switch\/sucrose nonfermenting (SWI\/SNF) subunits were associated with higher rates of outlier retained introns across tumor types in The Cancer Genome Atlas data. Interestingly, RNA sequencing of isogenic SCCOHT cell lines demonstrated a role for SMARCA4 in intron retention (IR). Distinct protein\u2013protein interactions between splicing factors identified in SCCOHT cell lines supported a role for SMARCA4 in splicing regulation. Furthermore, SWI\/SNF localized to genes, which were differentially spliced. Mass spectrometry analyses confirmed expression of some of these novel peptides, and a subset of these are predicted to bind to MHC-I complexes. A pool of these novel peptides derived from retained introns in SCCOHT triggered proliferation and expression of TNF\u03b1 and INF\u03b3 in primary human T cells. Together, these data suggest that SMARCA4 loss in SCCOHT leads to IR. Furthermore, T-cell activation by novel peptides encoded by these tumor-specific splicing events suggests IR could be a source of tumor-associated antigens in SCCOHT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>SCCOHT, a rare ovarian cancer, features splicing dysregulation due to SMARCA4 loss that generates immunostimulatory peptides linked to potential immune responses and therapeutic avenues, challenging traditional views of the role of SMARCA4.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/0008-5472.can-24-0044","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T10:01:27Z","timestamp":1747994487000},"page":"2626-2642","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Loss of SMARCA4 Leads to Intron Retention and Generation of Tumor-Associated Antigens in Small Cell Carcinoma of the Ovary, Hypercalcemic Type"],"prefix":"10.1158","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6034-007X","authenticated-orcid":false,"given":"Elizabeth A.","family":"Raupach","sequence":"first","affiliation":[{"name":"1Integrated Cancer Genomics, Translational Genomics Research Institute, Phoenix, Arizona."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0755-3294","authenticated-orcid":false,"given":"Apurva M.","family":"Hegde","sequence":"additional","affiliation":[{"name":"2Cancer & Cell Biology Division, Translational Genomics Research Institute, Phoenix, Arizona."},{"name":"3Integrated Mass Spectrometry Shared Resource, City of Hope Comprehensive Cancer Center, Duarte, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9089-2254","authenticated-orcid":false,"given":"Krystine","family":"Garcia-Mansfield","sequence":"additional","affiliation":[{"name":"2Cancer & Cell Biology Division, Translational Genomics Research Institute, Phoenix, Arizona."},{"name":"3Integrated Mass Spectrometry Shared Resource, City of Hope Comprehensive Cancer Center, Duarte, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1853-2884","authenticated-orcid":false,"given":"Marice","family":"Alcantara","sequence":"additional","affiliation":[{"name":"4Immuno-Oncology Department, Beckman Research Institute, City of Hope National Medical Center, Duarte, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1430-5692","authenticated-orcid":false,"given":"David L.","family":"Rose","sequence":"additional","affiliation":[{"name":"5Department of Shared Resources, Beckman Research Institute of the City of Hope, Duarte, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9378-8380","authenticated-orcid":false,"given":"Rebecca F.","family":"Halperin","sequence":"additional","affiliation":[{"name":"1Integrated Cancer Genomics, Translational Genomics Research Institute, Phoenix, Arizona."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5790-8843","authenticated-orcid":false,"given":"Krystal A.","family":"Orlando","sequence":"additional","affiliation":[{"name":"6Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina."},{"name":"7Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9700-4785","authenticated-orcid":false,"given":"Jessica D.","family":"Lang","sequence":"additional","affiliation":[{"name":"1Integrated Cancer Genomics, Translational Genomics Research Institute, Phoenix, Arizona."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8365-9916","authenticated-orcid":false,"given":"Ritin","family":"Sharma","sequence":"additional","affiliation":[{"name":"2Cancer & Cell Biology Division, Translational Genomics Research Institute, Phoenix, Arizona."},{"name":"3Integrated Mass Spectrometry Shared Resource, City of Hope Comprehensive Cancer Center, Duarte, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1279-7785","authenticated-orcid":false,"given":"Victoria","family":"David-Dirgo","sequence":"additional","affiliation":[{"name":"2Cancer & Cell Biology Division, Translational Genomics Research Institute, Phoenix, Arizona."},{"name":"3Integrated Mass Spectrometry Shared Resource, City of Hope Comprehensive Cancer Center, Duarte, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4353-1149","authenticated-orcid":false,"given":"Salvatore J.","family":"Facista","sequence":"additional","affiliation":[{"name":"1Integrated Cancer Genomics, Translational Genomics Research Institute, Phoenix, Arizona."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0026-1953","authenticated-orcid":false,"given":"Rayvon","family":"Moore","sequence":"additional","affiliation":[{"name":"6Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina."},{"name":"7Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0163-9477","authenticated-orcid":false,"given":"Rochelle","family":"Kofman","sequence":"additional","affiliation":[{"name":"2Cancer & Cell Biology Division, Translational Genomics Research Institute, Phoenix, Arizona."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7541-7052","authenticated-orcid":false,"given":"Zoe N.","family":"Jensen","sequence":"additional","affiliation":[{"name":"2Cancer & Cell Biology Division, Translational Genomics Research Institute, Phoenix, Arizona."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3287-5779","authenticated-orcid":false,"given":"Victoria L.","family":"Zismann","sequence":"additional","affiliation":[{"name":"1Integrated Cancer Genomics, Translational Genomics Research Institute, Phoenix, Arizona."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2924-1126","authenticated-orcid":false,"given":"Anthony N.","family":"Karnezis","sequence":"additional","affiliation":[{"name":"8Department of Pathology and Laboratory Medicine, UC Davis, Sacramento, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2970-9510","authenticated-orcid":false,"given":"Yemin","family":"Wang","sequence":"additional","affiliation":[{"name":"9Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada."},{"name":"10Department of Molecular Oncology, British Columbia Cancer Research Institute, Vancouver, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7491-5797","authenticated-orcid":false,"given":"Lynda B.","family":"Bennett","sequence":"additional","affiliation":[{"name":"11Baylor Scott & White Research Institute, Dallas, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0447-5682","authenticated-orcid":false,"given":"Timothy G.","family":"Whitsett","sequence":"additional","affiliation":[{"name":"12Translational Genomics Research Institute, Phoenix, Arizona."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6003-1816","authenticated-orcid":false,"given":"Marcin","family":"Kortylewski","sequence":"additional","affiliation":[{"name":"4Immuno-Oncology Department, Beckman Research Institute, City of Hope National Medical Center, Duarte, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7192-8699","authenticated-orcid":false,"given":"William P.D.","family":"Hendricks","sequence":"additional","affiliation":[{"name":"1Integrated Cancer Genomics, Translational Genomics Research Institute, Phoenix, Arizona."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4934-3322","authenticated-orcid":false,"given":"David G.","family":"Huntsman","sequence":"additional","affiliation":[{"name":"9Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada."},{"name":"10Department of Molecular Oncology, British Columbia Cancer Research Institute, Vancouver, Canada."},{"name":"13Department of Obstetrics and Gynaecology, University of British Columbia, Vancouver, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5909-1774","authenticated-orcid":false,"given":"Lorna","family":"Rodriguez-Rodriguez","sequence":"additional","affiliation":[{"name":"14Division of Gynecologic Oncology, Department of Surgery, City of Hope National Medical Center, Los Angeles, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1827-2309","authenticated-orcid":false,"given":"Bernard E.","family":"Weissman","sequence":"additional","affiliation":[{"name":"6Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina."},{"name":"7Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0183-4202","authenticated-orcid":false,"given":"Jeffrey M.","family":"Trent","sequence":"additional","affiliation":[{"name":"1Integrated Cancer Genomics, Translational Genomics Research Institute, Phoenix, Arizona."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1360-6039","authenticated-orcid":false,"given":"Patrick","family":"Pirrotte","sequence":"additional","affiliation":[{"name":"2Cancer & Cell Biology Division, Translational Genomics Research Institute, Phoenix, Arizona."},{"name":"3Integrated Mass Spectrometry Shared Resource, City of Hope Comprehensive Cancer Center, Duarte, California."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2025,5,23]]},"reference":[{"key":"2025071503072467600_bib1","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/ng.2628","article-title":"Proteomic and bioinformatic analysis of mammalian SWI\/SNF complexes identifies extensive roles in human malignancy","volume":"45","author":"Kadoch","year":"2013","journal-title":"Nat Genet"},{"key":"2025071503072467600_bib2","doi-asserted-by":"crossref","first-page":"e55119","DOI":"10.1371\/journal.pone.0055119","article-title":"The spectrum of SWI\/SNF mutations, ubiquitous in human cancers","volume":"8","author":"Shain","year":"2013","journal-title":"PLoS One"},{"key":"2025071503072467600_bib3","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/28212","article-title":"Truncating mutations of hSNF5\/INI1 in aggressive paediatric cancer","volume":"394","author":"Versteege","year":"1998","journal-title":"Nature"},{"key":"2025071503072467600_bib4","first-page":"74","article-title":"Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors","volume":"59","author":"Biegel","year":"1999","journal-title":"Cancer Res"},{"key":"2025071503072467600_bib5","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/ng.2931","article-title":"Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type","volume":"46","author":"Witkowski","year":"2014","journal-title":"Nat Genet"},{"key":"2025071503072467600_bib6","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/modpathol.2012.175","article-title":"Epithelioid sarcoma is associated with a high percentage of SMARCB1 deletions","volume":"26","author":"Sullivan","year":"2013","journal-title":"Mod Pathol"},{"key":"2025071503072467600_bib7","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/ng.2928","article-title":"Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4","volume":"46","author":"Ramos","year":"2014","journal-title":"Nat Genet"},{"key":"2025071503072467600_bib8","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/ng.2922","article-title":"Recurrent SMARCA4 mutations in small cell carcinoma of the ovary","volume":"46","author":"Jelinic","year":"2014","journal-title":"Nat Genet"},{"key":"2025071503072467600_bib9","doi-asserted-by":"crossref","first-page":"18404","DOI":"10.3748\/wjg.v20.i48.18404","article-title":"Clinicopathologic and prognostic relevance of ARID1A protein loss in colorectal cancer","volume":"20","author":"Wei","year":"2014","journal-title":"World J Gastroenterol"},{"key":"2025071503072467600_bib10","first-page":"560","article-title":"Loss of BRG1\/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosis","volume":"63","author":"Reisman","year":"2003","journal-title":"Cancer Res"},{"key":"2025071503072467600_bib11","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3892\/ijo.2012.1723","article-title":"The clinical significance of SWI\/SNF complex in pancreatic cancer","volume":"42","author":"Numata","year":"2013","journal-title":"Int J Oncol"},{"key":"2025071503072467600_bib12","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.eururo.2012.09.005","article-title":"Clinical and pathologic impact of select chromatin-modulating tumor suppressors in clear cell renal cell carcinoma","volume":"63","author":"Hakimi","year":"2013","journal-title":"Eur Urol"},{"key":"2025071503072467600_bib13","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.humpath.2012.11.007","article-title":"Loss of ARID1A\/BAF250a expression is linked to tumor progression and adverse prognosis in cervical cancer","volume":"44","author":"Cho","year":"2013","journal-title":"Hum Pathol"},{"key":"2025071503072467600_bib14","doi-asserted-by":"crossref","first-page":"e59772","DOI":"10.1371\/journal.pone.0059772","article-title":"BRG1 is a prognostic marker and potential therapeutic target in human breast cancer","volume":"8","author":"Bai","year":"2013","journal-title":"PLoS One"},{"key":"2025071503072467600_bib15","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nm.3480","article-title":"ARID1B is a specific vulnerability in ARID1A-mutant cancers","volume":"20","author":"Helming","year":"2014","journal-title":"Nat Med"},{"key":"2025071503072467600_bib16","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1073\/pnas.1316793111","article-title":"Functional epigenetics approach identifies BRM\/SMARCA2 as a critical synthetic lethal target in BRG1-deficient cancers","volume":"111","author":"Hoffman","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025071503072467600_bib17","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/s41392-023-01647-6","article-title":"Bromodomain and extraterminal (BET) proteins: biological functions, diseases, and targeted therapy","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"2025071503072467600_bib18","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ccr.2010.09.006","article-title":"Epigenetic antagonism between polycomb and SWI\/SNF complexes during oncogenic transformation","volume":"18","author":"Wilson","year":"2010","journal-title":"Cancer Cell"},{"key":"2025071503072467600_bib19","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/path.4912","article-title":"The histone methyltransferase EZH2 is a therapeutic target in small cell carcinoma of the ovary, hypercalcaemic type","volume":"242","author":"Wang","year":"2017","journal-title":"J Pathol"},{"key":"2025071503072467600_bib20","doi-asserted-by":"crossref","first-page":"7922","DOI":"10.1073\/pnas.1303800110","article-title":"Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2","volume":"110","author":"Knutson","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025071503072467600_bib21","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1158\/1078-0432.CCR-17-1928","article-title":"Ponatinib shows potent antitumor activity in small cell carcinoma of the ovary hypercalcemic type (SCCOHT) through multikinase inhibition","volume":"24","author":"Lang","year":"2018","journal-title":"Clin Cancer Res"},{"key":"2025071503072467600_bib22","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41467-018-06958-9","article-title":"CDK4\/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary","volume":"10","author":"Xue","year":"2019","journal-title":"Nat Commun"},{"key":"2025071503072467600_bib23","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41467-019-08380-1","article-title":"SMARCA4 loss is synthetic lethal with CDK4\/6 inhibition in non-small cell lung cancer","volume":"10","author":"Xue","year":"2019","journal-title":"Nat Commun"},{"key":"2025071503072467600_bib24","doi-asserted-by":"crossref","first-page":"e0235705","DOI":"10.1371\/journal.pone.0235705","article-title":"The novel reversible LSD1 inhibitor SP-2577 promotes anti-tumor immunity in SWItch\/Sucrose-NonFermentable (SWI\/SNF) complex mutated ovarian cancer","volume":"15","author":"Soldi","year":"2020","journal-title":"PLoS One"},{"key":"2025071503072467600_bib25","doi-asserted-by":"crossref","first-page":"5295","DOI":"10.18632\/oncotarget.2092","article-title":"Loss of ARID1A expression sensitizes cancer cells to PI3K- and AKT-inhibition","volume":"5","author":"Samartzis","year":"2014","journal-title":"Oncotarget"},{"key":"2025071503072467600_bib26","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/s41591-018-0052-4","article-title":"An inhibitor of oxidative phosphorylation exploits cancer vulnerability","volume":"24","author":"Molina","year":"2018","journal-title":"Nat Med"},{"key":"2025071503072467600_bib27","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/s41591-018-0019-5","article-title":"Mutations in the SWI\/SNF complex induce a targetable dependence on oxidative phosphorylation in lung cancer","volume":"24","author":"Lissanu Deribe","year":"2018","journal-title":"Nat Med"},{"key":"2025071503072467600_bib28","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1158\/2159-8290.CD-14-0849","article-title":"ARID1A deficiency impairs the DNA damage checkpoint and sensitizes cells to PARP inhibitors","volume":"5","author":"Shen","year":"2015","journal-title":"Cancer Discov"},{"key":"2025071503072467600_bib29","doi-asserted-by":"crossref","first-page":"5584","DOI":"10.1158\/1078-0432.CCR-18-4222","article-title":"Loss of ARID1A in tumor cells renders selective vulnerability to combined ionizing radiation and PARP inhibitor therapy","volume":"25","author":"Park","year":"2019","journal-title":"Clin Cancer Res"},{"key":"2025071503072467600_bib30","doi-asserted-by":"crossref","first-page":"4116","DOI":"10.1038\/s41467-018-06656-6","article-title":"SWI\/SNF catalytic subunits\u2019 switch drives resistance to EZH2 inhibitors in ARID1A-mutated cells","volume":"9","author":"Wu","year":"2018","journal-title":"Nat Commun"},{"key":"2025071503072467600_bib31","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1126\/science.aaa4971","article-title":"Neoantigens in cancer immunotherapy","volume":"348","author":"Schumacher","year":"2015","journal-title":"Science"},{"key":"2025071503072467600_bib32","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"2025071503072467600_bib33","first-page":"389","article-title":"[Photodynamic therapy of malignant brain tumors]","volume":"99","author":"Kostron","year":"1987","journal-title":"Wien Klin Wochenschr"},{"key":"2025071503072467600_bib34","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"key":"2025071503072467600_bib35","doi-asserted-by":"crossref","first-page":"916790","DOI":"10.3389\/fonc.2022.916790","article-title":"Case report: a durable response to camrelizumab and apatinib combination therapy in a heavily treated small cell carcinoma of the ovary, hypercalcemic type","volume":"12","author":"Li","year":"2022","journal-title":"Front Oncol"},{"key":"2025071503072467600_bib36","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/jnci\/djx277","article-title":"Immune-active microenvironment in small cell carcinoma of the ovary, hypercalcemic type: rationale for immune checkpoint blockade","volume":"110","author":"Jelinic","year":"2018","journal-title":"J Natl Cancer Inst"},{"key":"2025071503072467600_bib37","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1158\/2326-6066.CIR-19-0866","article-title":"Mammalian SWI\/SNF complex genomic alterations and immune checkpoint blockade in solid tumors","volume":"8","author":"Abou Alaiwi","year":"2020","journal-title":"Cancer Immunol Res"},{"key":"2025071503072467600_bib38","doi-asserted-by":"crossref","first-page":"5701","DOI":"10.1158\/1078-0432.CCR-20-1825","article-title":"The genomic landscape of SMARCA4 alterations and associations with outcomes in patients with lung cancer","volume":"26","author":"Schoenfeld","year":"2020","journal-title":"Clin Cancer Res"},{"key":"2025071503072467600_bib39","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1126\/science.aan5951","article-title":"Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma","volume":"359","author":"Miao","year":"2018","journal-title":"Science"},{"key":"2025071503072467600_bib40","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.jtho.2021.03.024","article-title":"SMARCA4 and other SWItch\/sucrose NonFermentable family genomic alterations in NSCLC: clinicopathologic characteristics and outcomes to immune checkpoint inhibition","volume":"16","author":"Alessi","year":"2021","journal-title":"J Thorac Oncol"},{"key":"2025071503072467600_bib41","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.4049\/jimmunol.1402454","article-title":"Peptide splicing in the proteasome creates a novel type of antigen with an isopeptide linkage","volume":"195","author":"Berkers","year":"2015","journal-title":"J Immunol"},{"key":"2025071503072467600_bib42","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1101\/gr.199935.115","article-title":"Large-scale analysis of genome and transcriptome alterations in multiple tumors unveils novel cancer-relevant splicing networks","volume":"26","author":"Sebesty\u00e9n","year":"2016","journal-title":"Genome Res"},{"key":"2025071503072467600_bib43","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.celrep.2018.03.052","article-title":"Systematic analysis of splice-site-creating mutations in cancer","volume":"23","author":"Jayasinghe","year":"2018","journal-title":"Cell Rep"},{"key":"2025071503072467600_bib44","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ccell.2018.07.001","article-title":"Comprehensive analysis of alternative splicing across tumors from 8,705 patients","volume":"34","author":"Kahles","year":"2018","journal-title":"Cancer Cell"},{"key":"2025071503072467600_bib45","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41577-019-0195-7","article-title":"Alternative mRNA splicing in cancer immunotherapy","volume":"19","author":"Frankiw","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"2025071503072467600_bib46","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nsmb1030","article-title":"The human SWI\/SNF subunit Brm is a regulator of alternative splicing","volume":"13","author":"Batsch\u00e9","year":"2006","journal-title":"Nat Struct Mol Biol"},{"key":"2025071503072467600_bib47","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41588-018-0272-z","article-title":"SWI\/SNF remains localized to chromatin in the presence of SCHLAP1","volume":"51","author":"Raab","year":"2019","journal-title":"Nat Genet"},{"key":"2025071503072467600_bib48","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00438-022-01863-9","article-title":"The SWI\/SNF subunit BRG1 affects alternative splicing by changing RNA binding factor interactions with nascent RNA","volume":"297","author":"Ga\u00f1ez-Zapater","year":"2022","journal-title":"Mol Genet Genomics"},{"key":"2025071503072467600_bib49","doi-asserted-by":"crossref","first-page":"e1000470","DOI":"10.1371\/journal.pgen.1000470","article-title":"SWI\/SNF associates with nascent pre-mRNPs and regulates alternative pre-mRNA processing","volume":"5","author":"Tyagi","year":"2009","journal-title":"PLoS Genet"},{"key":"2025071503072467600_bib50","doi-asserted-by":"crossref","first-page":"8557","DOI":"10.1093\/nar\/gky438","article-title":"SWI\/SNF interacts with cleavage and polyadenylation factors and facilitates pre-mRNA 3\u2032 end processing","volume":"46","author":"Yu","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"2025071503072467600_bib51","doi-asserted-by":"crossref","first-page":"e967148","DOI":"10.4161\/2167549X.2014.967148","article-title":"Loss of the tumor suppressor SMARCA4 in small cell carcinoma of the ovary, hypercalcemic type (SCCOHT)","volume":"2","author":"Ramos","year":"2014","journal-title":"Rare Dis"},{"key":"2025071503072467600_bib52","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/path.4633","article-title":"Dual loss of the SWI\/SNF complex ATPases SMARCA4\/BRG1 and SMARCA2\/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type","volume":"238","author":"Karnezis","year":"2016","journal-title":"J Pathol"},{"key":"2025071503072467600_bib53","doi-asserted-by":"crossref","first-page":"10740","DOI":"10.1038\/s41598-021-89938-2","article-title":"Improved methods for RNAseq-based alternative splicing analysis","volume":"11","author":"Halperin","year":"2021","journal-title":"Sci Rep"},{"key":"2025071503072467600_bib54","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3892\/ijo.2012.1468","article-title":"A tumor-derived population (SCCOHT-1) as cellular model for a small cell ovarian carcinoma of the hypercalcemic type","volume":"41","author":"Otte","year":"2012","journal-title":"Int J Oncol"},{"key":"2025071503072467600_bib55","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/jbmr.5650010309","article-title":"Differential cyclic AMP responses to calcitonin among human ovarian carcinoma cell lines: a calcitonin-responsive line derived from a rare tumor type","volume":"1","author":"Upchurch","year":"1986","journal-title":"J Bone Miner Res"},{"key":"2025071503072467600_bib56","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1158\/1535-7163.MCT-18-0348","article-title":"Histone deacetylase inhibitors synergize with catalytic inhibitors of EZH2 to exhibit antitumor activity in small cell carcinoma of the ovary, hypercalcemic type","volume":"17","author":"Wang","year":"2018","journal-title":"Mol Cancer Ther"},{"key":"2025071503072467600_bib57","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ygyno.2020.12.004","article-title":"Re-assigning the histologic identities of COV434 and TOV-112D ovarian cancer cell lines","volume":"160","author":"Karnezis","year":"2021","journal-title":"Gynecol Oncol"},{"key":"2025071503072467600_bib58","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nature10348","article-title":"Ebola virus entry requires the cholesterol transporter Niemann-Pick C1","volume":"477","author":"Carette","year":"2011","journal-title":"Nature"},{"key":"2025071503072467600_bib59","doi-asserted-by":"crossref","first-page":"e59073","DOI":"10.7554\/eLife.59073","article-title":"Re-expression of SMARCA4\/BRG1 in small cell carcinoma of ovary, hypercalcemic type (SCCOHT) promotes an epithelial-like gene signature through an AP-1-dependent mechanism","volume":"9","author":"Orlando","year":"2020","journal-title":"Elife"},{"key":"2025071503072467600_bib60","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/bioinformatics\/btp120","article-title":"TopHat: discovering splice junctions with RNA-Seq","volume":"25","author":"Trapnell","year":"2009","journal-title":"Bioinformatics"},{"key":"2025071503072467600_bib61","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/nprot.2012.016","article-title":"Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks","volume":"7","author":"Trapnell","year":"2012","journal-title":"Nat Protoc"},{"key":"2025071503072467600_bib62","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/gm403","article-title":"HLA typing from RNA-Seq sequence reads","volume":"4","author":"Boegel","year":"2012","journal-title":"Genome Med"},{"key":"2025071503072467600_bib63","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/978-1-4939-8546-3_13","article-title":"PHLAT: inference of high-resolution HLA types from RNA and whole exome sequencing","volume":"1802","author":"Bai","year":"2018","journal-title":"Methods Mol Biol"},{"key":"2025071503072467600_bib64","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.4049\/jimmunol.1700893","article-title":"NetMHCpan-4.0: improved peptide-MHC class I interaction predictions integrating eluted ligand and peptide binding affinity data","volume":"199","author":"Jurtz","year":"2017","journal-title":"J Immunol"},{"key":"2025071503072467600_bib65","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.cell.2017.09.050","article-title":"MHC-I genotype restricts the oncogenic mutational landscape","volume":"171","author":"Marty","year":"2017","journal-title":"Cell"},{"key":"2025071503072467600_bib66","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/bioinformatics\/btp101","article-title":"ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks","volume":"25","author":"Bindea","year":"2009","journal-title":"Bioinformatics"},{"key":"2025071503072467600_bib67","doi-asserted-by":"crossref","first-page":"D1057","DOI":"10.1093\/nar\/gku1113","article-title":"The Goa database: gene Ontology annotation updates for 2015","volume":"43","author":"Huntley","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"2025071503072467600_bib68","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1038\/nprot.2006.468","article-title":"In-gel digestion for mass spectrometric characterization of proteins and proteomes","volume":"1","author":"Shevchenko","year":"2006","journal-title":"Nat Protoc"},{"key":"2025071503072467600_bib69","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/S0022-2275(20)41968-6","article-title":"Stereospecific synthesis and two-dimensional 1H-NMR investigation of isoursocholic acid","volume":"32","author":"Dayal","year":"1991","journal-title":"J Lipid Res"},{"key":"2025071503072467600_bib70","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jprot.2013.10.023","article-title":"SAINTexpress: improvements and additional features in Significance Analysis of INTeractome software","volume":"100","author":"Teo","year":"2014","journal-title":"J Proteomics"},{"key":"2025071503072467600_bib71","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/s41588-019-0363-5","article-title":"The ATPase module of mammalian SWI\/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting","volume":"51","author":"Pan","year":"2019","journal-title":"Nat Genet"},{"key":"2025071503072467600_bib72","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.1923","article-title":"Fast gapped-read alignment with Bowtie 2","volume":"9","author":"Langmead","year":"2012","journal-title":"Nat Methods"},{"key":"2025071503072467600_bib73","doi-asserted-by":"crossref","first-page":"giab008","DOI":"10.1093\/gigascience\/giab008","article-title":"Twelve years of SAMtools and BCFtools","volume":"10","author":"Danecek","year":"2021","journal-title":"Gigascience"},{"key":"2025071503072467600_bib74","doi-asserted-by":"crossref","first-page":"W160","DOI":"10.1093\/nar\/gkw257","article-title":"deepTools2: a next generation web server for deep-sequencing data analysis","volume":"44","author":"Ram\u00edrez","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"2025071503072467600_bib75","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature11247","article-title":"An integrated encyclopedia of DNA elements in the human genome","volume":"489","author":"ENCODE Project Consortium","year":"2012","journal-title":"Nature"},{"key":"2025071503072467600_bib76","doi-asserted-by":"crossref","first-page":"R137","DOI":"10.1186\/gb-2008-9-9-r137","article-title":"Model-based analysis of ChIP-seq (MACS)","volume":"9","author":"Zhang","year":"2008","journal-title":"Genome Biol"},{"key":"2025071503072467600_bib77","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1093\/bioinformatics\/btv145","article-title":"ChIPseeker: an R\/Bioconductor package for ChIP peak annotation, comparison and visualization","volume":"31","author":"Yu","year":"2015","journal-title":"Bioinformatics"},{"key":"2025071503072467600_bib78","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1186\/s12859-018-2579-2","article-title":"NGmerge: merging paired-end reads via novel empirically-derived models of sequencing errors","volume":"19","author":"Gaspar","year":"2018","journal-title":"BMC Bioinformatics"},{"key":"2025071503072467600_bib79","first-page":"160","article-title":"Tension pneumoperitoneum: a surgical emergency","volume":"39","author":"Higgins","year":"1988","journal-title":"Br J Hosp Med"},{"key":"2025071503072467600_bib80","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/gkv1191","article-title":"csaw: a Bioconductor package for differential binding analysis of ChIP-seq data using sliding windows","volume":"44","author":"Lun","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"2025071503072467600_bib81","doi-asserted-by":"crossref","first-page":"e95","DOI":"10.1093\/nar\/gku351","article-title":"De novo detection of differentially bound regions for ChIP-seq data using peaks and windows: controlling error rates correctly","volume":"42","author":"Lun","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"2025071503072467600_bib82","doi-asserted-by":"crossref","first-page":"e173290","DOI":"10.1001\/jamaoncol.2017.3290","article-title":"Dose-response association of CD8+ tumor-infiltrating lymphocytes and survival time in high-grade serous ovarian cancer","volume":"3","author":"Goode","year":"2017","journal-title":"JAMA Oncol"},{"key":"2025071503072467600_bib83","doi-asserted-by":"crossref","first-page":"e6412","DOI":"10.1371\/journal.pone.0006412","article-title":"Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors","volume":"4","author":"Milne","year":"2009","journal-title":"PLoS One"},{"key":"2025071503072467600_bib84","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1093\/bioinformatics\/btw076","article-title":"SplAdder: identification, quantification and testing of alternative splicing events from RNA-Seq data","volume":"32","author":"Kahles","year":"2016","journal-title":"Bioinformatics"},{"key":"2025071503072467600_bib85","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/nbt.4239","article-title":"Intron retention is a source of neoepitopes in cancer","volume":"36","author":"Smart","year":"2018","journal-title":"Nat Biotechnol"},{"key":"2025071503072467600_bib86","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ygyno.2023.12.016","article-title":"A dramatic response to checkpoint inhibitor in a woman with small cell carcinoma of the hypercalcemic type of the ovary","volume":"181","author":"Altmann","year":"2024","journal-title":"Gynecol Oncol"},{"key":"2025071503072467600_bib87","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/s41588-019-0477-9","article-title":"Systematic characterization of BAF mutations provides insights into intracomplex synthetic lethalities in human cancers","volume":"51","author":"Schick","year":"2019","journal-title":"Nat Genet"},{"key":"2025071503072467600_bib88","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1158\/1078-0432.CCR-19-3797","article-title":"Small-cell carcinoma of the ovary, hypercalcemic type-genetics, new treatment targets, and current management guidelines","volume":"26","author":"Tischkowitz","year":"2020","journal-title":"Clin Cancer Res"},{"key":"2025071503072467600_bib89","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.path.2016.01.005","article-title":"Small-cell carcinoma of the ovary of hypercalcemic type (malignant rhabdoid tumor of the ovary): a review with recent developments on pathogenesis","volume":"9","author":"Witkowski","year":"2016","journal-title":"Surg Pathol Clin"},{"key":"2025071503072467600_bib90","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.annonc.2021.02.006","article-title":"High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types","volume":"32","author":"McGrail","year":"2021","journal-title":"Ann Oncol"},{"key":"2025071503072467600_bib91","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.3390\/cells9061496","article-title":"Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT) beyond SMARCA4 mutations: a comprehensive genomic analysis","volume":"9","author":"Auguste","year":"2020","journal-title":"Cells"},{"key":"2025071503072467600_bib92","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s40364-020-00220-5","article-title":"The biological function and clinical significance of SF3B1 mutations in cancer","volume":"8","author":"Zhou","year":"2020","journal-title":"Biomark Res"},{"key":"2025071503072467600_bib93","doi-asserted-by":"crossref","first-page":"e1005074","DOI":"10.1371\/journal.pgen.1005074","article-title":"Genetic interaction mapping reveals a role for the SWI\/SNF nucleosome remodeler in spliceosome activation in fission yeast","volume":"11","author":"Patrick","year":"2015","journal-title":"PLoS Genet"},{"key":"2025071503072467600_bib94","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/ncb3629","article-title":"The impact of cellular metabolism on chromatin dynamics and epigenetics","volume":"19","author":"Reid","year":"2017","journal-title":"Nat Cell Biol"},{"key":"2025071503072467600_bib95","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nrm.2016.140","article-title":"Metabolic regulation of gene expression through histone acylations","volume":"18","author":"Sabari","year":"2017","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2025071503072467600_bib96","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13148-020-00862-0","article-title":"Symphony of epigenetic and metabolic regulation-interaction between the histone methyltransferase EZH2 and metabolism of tumor","volume":"12","author":"Zhang","year":"2020","journal-title":"Clin Epigenetics"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/doi\/10.1158\/0008-5472.CAN-24-0044\/3609175\/can-24-0044.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/85\/14\/2626\/3628927\/can-24-0044.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/85\/14\/2626\/3628927\/can-24-0044.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T07:07:41Z","timestamp":1752563261000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/85\/14\/2626\/763448\/Loss-of-SMARCA4-Leads-to-Intron-Retention-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,23]]},"references-count":96,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2025,5,23]]},"published-print":{"date-parts":[[2025,7,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-24-0044","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.29568227","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.29568230","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.7928399","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,23]]}}}